MGRM — Monogram Orthopaedics Income Statement
0.000.00%
Last trade - 00:00
- $130.18m
- $116.59m
- $0.37m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.628 | 0 | 0.365 |
Cost of Revenue | |||||
Gross Profit | — | — | 0.17 | 0 | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 1.68 | 6.85 | 10.9 | 10.6 | 17.6 |
Operating Profit | -1.68 | -6.85 | -10.3 | -10.6 | -17.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.8 | -9.07 | -11.8 | -13.7 | -13.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.8 | -9.07 | -11.8 | -13.7 | -13.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.8 | -9.07 | -11.8 | -13.7 | -13.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.8 | -9.07 | -11.8 | -13.7 | -13.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.061 | -0.31 | -0.404 | -0.468 | -0.613 |